March 20 (Reuters) – U.S. consumer health products maker Prestige Consumer Healthcare said on Friday it would buy the Breathe Right brand and other assets from Foundation Consumer Healthcare in a deal valued at $1.045 billion.
The Breathe Right brand, which is set to be the largest in Prestige’s portfolio, had a revenue of about $200 million and core profit of $95 million in 2025.
The transaction is expected to close during the first half of 2027.
(Reporting by Sahil Pandey and Koyena Das in Bengaluru; Editing by Shreya Biswas)
Comments